Αποτελέσματα Αναζήτησης
4 Απρ 2020 · Several studies have shown that surgical approach has the advantage of a more durable relief of symptoms and the need of fewer re-interventions, at the cost of higher procedure-related risks and longer hospital stay.
- Figure 4
Images in this article. Click on the image to see a larger...
- Open in a Separate Window
Endoscopic ultrasound-guided gastroenterostomy with the...
- PMC Free Article
The use of covered stents in the duodenum may however lead...
- Comparison of Clinical Outcomes and Costs
Results. The MedPAR claims data evaluated 425 stenting and...
- Figure 4
6 Ιαν 2023 · In a 2022 study, researchers examined the survival rate of people 40 to 74 years old and people over the age of 75 who were treated for bowel obstruction between 2009 and 2019. Researchers found...
3 Μαρ 2019 · Core tip: This review was designed to provide present evidence of the indication, technique, outcomes, benefits, and risks of colon stenting and emergency surgery in acute malignant colonic obstruction through the analysis of previously published studies with 1A evidence and current guidelines.
18 Οκτ 2021 · Outcomes in the literature to date are summarized for various malignant bowel obstruction treatment strategies, including surgical and non-surgical approaches, as well as a discussion of the role of total parenteral nutrition and chemotherapy in holistic malignant bowel obstruction management.
The role of surgery in malignant bowel obstruction needs careful evaluation, using validated outcome measures of symptom control and quality of life scores. Further information could include re-obstruction rates together with the morbidity associated with the various surgical procedures.
1 Σεπ 2017 · In fact, the cost difference between surgery after the 1st SBO recurrence and the 2nd SBO recurrence was $1,643, with an increase of 0.135 quality adjusted life years (QALYs).
Endoscopic stenting versus operative gastrojejunostomy for malignant gastric outlet obstruction-a systematic review and meta-analysis of randomized and non-randomized trials.
